- Home
- FMBH vs AQST Comparison
FMBH vs AQST Comparison
Compare FMBH & AQST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FMBH
- AQST
- Stock Information
- Founded
- FMBH 1865
- AQST 2004
- Country
- FMBH United States
- AQST United States
- Employees
- FMBH N/A
- AQST N/A
- Industry
- FMBH Major Banks
- AQST Biotechnology: Pharmaceutical Preparations
- Sector
- FMBH Finance
- AQST Health Care
- Exchange
- FMBH Nasdaq
- AQST Nasdaq
- Market Cap
- FMBH 974.1M
- AQST 809.3M
- IPO Year
- FMBH N/A
- AQST 2018
- Fundamental
- Price
- FMBH $35.73
- AQST $6.82
- Analyst Decision
- FMBH Hold
- AQST Strong Buy
- Analyst Count
- FMBH 5
- AQST 6
- Target Price
- FMBH $43.40
- AQST $10.33
- AVG Volume (30 Days)
- FMBH 67.7K
- AQST 3.1M
- Earning Date
- FMBH 10-30-2025
- AQST 11-05-2025
- Dividend Yield
- FMBH 2.80%
- AQST N/A
- EPS Growth
- FMBH 12.54
- AQST N/A
- EPS
- FMBH 3.65
- AQST N/A
- Revenue
- FMBH $335,099,000.00
- AQST $44,132,000.00
- Revenue This Year
- FMBH N/A
- AQST N/A
- Revenue Next Year
- FMBH $4.16
- AQST $51.39
- P/E Ratio
- FMBH $9.79
- AQST N/A
- Revenue Growth
- FMBH 5.91
- AQST N/A
- 52 Week Low
- FMBH $27.58
- AQST $2.12
- 52 Week High
- FMBH $43.86
- AQST $7.55
- Technical
- Relative Strength Index (RSI)
- FMBH 41.94
- AQST 57.28
- Support Level
- FMBH $36.32
- AQST $6.39
- Resistance Level
- FMBH $37.20
- AQST $6.93
- Average True Range (ATR)
- FMBH 1.12
- AQST 0.39
- MACD
- FMBH 0.01
- AQST -0.11
- Stochastic Oscillator
- FMBH 39.55
- AQST 37.07
About FMBH First Mid Bancshares Inc.
First Mid Bancshares Inc is a United States based financial holding company. Through its wholly-owned subsidiary, First Mid Bank, it is engaged in the business of banking. The Company offers trust, farm services, investment services, and retirement planning through its wholly owned subsidiary, it also provides data processing services to affiliates and insurance products and services to customers through its subsidiary. The company's operations cover community banking, wealth management and insurance services. Key revenue is derived from the provision of community banking services.
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.